Ondansetron ODT 4 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F6DHW
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,619
Award facts
- Contract value 100% obligated
- $3,619.28 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $3,619.28 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units) on January 22, 2026, with completion expected by January 23, 2026. This is a non-set-aside, competitively awarded contract with performance in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031, which serves as the primary vehicle for delivering comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, maintains a significant portfolio of federal medical procurement contracts predominantly with the Defense Logistics Agency. The company's capabilities encompass delivery of specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains in support of military treatment facilities, veterans' healthcare programs, and other federal medical institutions. This particular delivery order for Ondansetron, an anti-nausea medication commonly used in clinical and medical settings, exemplifies the routine pharmaceutical supply operations conducted under the broader DLA Troop Support Medical contract vehicle.
Quick answers
Who was awarded contract SPE2DR26F6DHW?
SPE2DR26F6DHW was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26F6DHW worth?
The government has obligated $3,619 on SPE2DR26F6DHW.
Is contract SPE2DR26F6DHW an order under another contract?
Yes. SPE2DR26F6DHW is a delivery order under SPE2DR25D2213, an indefinite delivery contract.
Was contract SPE2DR26F6DHW competed?
The extent of competition for SPE2DR26F6DHW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award